Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Exchange Rate Effect (2023 - 2025)

Tonix Pharmaceuticals Holding (TNXP) has 3 years of Exchange Rate Effect data on record, last reported at -$4000.0 in Q3 2025.

  • For Q3 2025, Exchange Rate Effect rose 76.47% year-over-year to -$4000.0; the TTM value through Sep 2025 reached $7000.0, up 123.33%, while the annual FY2024 figure was $4000.0, 106.15% up from the prior year.
  • Exchange Rate Effect reached -$4000.0 in Q3 2025 per TNXP's latest filing, roughly flat from -$4000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $24000.0 in Q4 2024 and bottomed at -$43000.0 in Q1 2023.
  • Average Exchange Rate Effect over 3 years is -$7800.0, with a median of -$6500.0 recorded in 2024.
  • Peak YoY movement for Exchange Rate Effect: surged 340.0% in 2024, then plummeted 500.0% in 2025.
  • A 3-year view of Exchange Rate Effect shows it stood at -$10000.0 in 2023, then skyrocketed by 340.0% to $24000.0 in 2024, then plummeted by 116.67% to -$4000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were -$4000.0 in Q3 2025, -$4000.0 in Q2 2025, and -$9000.0 in Q1 2025.